Rishu Takimoto, Takashi Kamigaki, Hisao Ito, Masashi Saito, Ken Takizawa, Kenzo Soejima, Hiroyuki Yasuda, Keiko Ohgino, Hideki Terai, Katsuro Tomita, et al. Safety evaluation of immune-cell therapy for malignant tumor in the Cancer Immune-cell Therapy Evaluation Group (CITEG). Cytotherapy. 2023
Hirono Tsutsumi, Hiroyuki Inoue, Yoshimasa Shiraishi, Aiko Hirayama, Takayuki Nakanishi, Hiroyuki Ando, Maako Nakajima, Seiji Shinozaki, Hiroaki Ogata, Koji Okamura, et al. Impact of increased plasma levels of calreticulin on prognosis of patients with advanced lung cancer undergoing combination treatment of chemotherapy and immune checkpoint inhibitors. Lung cancer (Amsterdam, Netherlands). 2023. 181. 107264-107264
Akira Sakamoto, Hiroyuki Inoue, Shohei Miyamoto, Shun Ito, Yasushi Soda, Kenzaburo Tani. Coxsackievirus A11 is an immunostimulatory oncolytic virus that induces complete tumor regression in a human non-small cell lung cancer. Scientific reports. 2023. 13. 1. 5924-5924
Nobumitsu Ikeuchi, Fumiyasu Igata, Eriko Kinoshita, Toshiaki Kawabata, Ibun Tan, Yusuke Osaki, Rikako Otsuka, Rintaro On, Takato Ikeda, Akira Nakao, et al. Real-world Efficacy and Safety of Atezolizumab Plus Bevacizumab, Paclitaxel and Carboplatin for First-line Treatment of Japanese Patients With Metastatic Non-squamous Non-small Cell Lung Cancer. Anticancer research. 2023. 43. 2. 713-724
Hirono Tsutsumi, Eiji Iwama, Ritsu Ibusuki, Atsushi Shimauchi, Keiichi Ota, Yasuto Yoneshima, Hiroyuki Inoue, Kentaro Tanaka, Yoichi Nakanishi, Isamu Okamoto. Mutant forms of EGFR promote HER2 trafficking through efficient formation of HER2-EGFR heterodimers. Lung cancer (Amsterdam, Netherlands). 2023. 175. 101-111
